drugset / Trial / NCT03553446

50% Effective Concentration of Sevoflurane for Immobility

NCT03553446

NaSingle-groupOpen-labelTreatment

Summary

Sevoflurane is as attractive inhalation agent fore deep sedation in children undergoing short invasive procedure because of lack of irritation to the respiratory tract, a pleasant odor and rapid clinical effect and recovery due to low blood gas partition coefficient. The aim of this study is to determine the optimum inspired concentration of sevoflurane required for immobility during botulinum toxin injection in spontaneously breathing children with cerebral palsy.

Timeline

Start
2018-07-29
Primary completion
2021-03-26
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Sevoflurane Other / unclassified 2 % Inhaled

Indications

No indication recorded.